These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23202798)

  • 21. Effect of corticotropin releasing factor receptor 1 antagonist on extracellular norepinephrine, dopamine and serotonin in hippocampus and prefrontal cortex of rats in vivo.
    Isogawa K; Akiyoshi J; Hikichi T; Yamamoto Y; Tsutsumi T; Nagayama H
    Neuropeptides; 2000; 34(3-4):234-9. PubMed ID: 11021986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of abecarnil on basal release of acetylcholine and dopamine in the rat brain.
    Imperato A; Dazzi L; Serra M; Gessa GL; Biggio G
    Eur J Pharmacol; 1994 Aug; 261(1-2):205-8. PubMed ID: 8001645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential acetylcholine release in the prefrontal cortex and hippocampus during pavlovian trace and delay conditioning.
    Flesher MM; Butt AE; Kinney-Hurd BL
    Neurobiol Learn Mem; 2011 Sep; 96(2):181-91. PubMed ID: 21514394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats.
    Peleg-Raibstein D; Pezze MA; Ferger B; Zhang WN; Murphy CA; Feldon J; Bast T
    Neuroscience; 2005; 132(1):219-32. PubMed ID: 15780480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat.
    Nair SG; Gudelsky GA
    Synapse; 2004 Sep; 53(4):202-7. PubMed ID: 15266551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Meltzer HY
    Psychopharmacology (Berl); 2003 May; 167(3):315-23. PubMed ID: 12664192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
    Pisanu A; Acquas E; Fenu S; Di Chiara G
    Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.
    Jaskiw GE; Kirkbride B; Newbould E; Young D; Durkalski V; Bongiovanni R
    Psychopharmacology (Berl); 2005 Jun; 179(4):713-24. PubMed ID: 15682305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.
    Li Z; Huang M; Ichikawa J; Dai J; Meltzer HY
    Neuropsychopharmacology; 2005 Nov; 30(11):1986-95. PubMed ID: 15900318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and intracerebral pharmacokinetics and pharmacodynamics modeling for the acetylcholine releasing effect of ginsenoside Rg1 in mPFC of A
    Xue W; Gao Y; Xie PP; Liu Y; Qi WY; Shi AX; Li KX
    J Asian Nat Prod Res; 2021 Mar; 23(3):294-306. PubMed ID: 33771049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions.
    Laplante F; Srivastava LK; Quirion R
    J Neurochem; 2004 Apr; 89(2):314-23. PubMed ID: 15056275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse.
    Reid RT; Lloyd GK; Rao TS
    Br J Pharmacol; 1999 Jul; 127(6):1486-94. PubMed ID: 10455300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolyl oligopeptidase inhibition decreases extracellular acetylcholine levels in rat hippocampus and prefrontal cortex.
    Jalkanen AJ; Leikas JV; Forsberg MM
    Neurosci Lett; 2014 Sep; 579():110-3. PubMed ID: 25064702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of synchronous perfusion of NaN3 in changes in content of cholinergic neurotransmitter in medial prefrontal cortex and hippocampal extra-cellular fluid].
    Zhang MY; Sun DD; Liu Y; Cui Y; Zhao XL; Zhang Y; Wang ZG; Wang DQ
    Zhongguo Zhong Yao Za Zhi; 2014 Feb; 39(3):488-92. PubMed ID: 24946553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prefrontal stimulation of GABAA receptors counteracts the corticolimbic hyperactivity produced by NMDA antagonists in the prefrontal cortex of the rat.
    Del Arco A; Ronzoni G; Mora F
    Psychopharmacology (Berl); 2011 Mar; 214(2):525-36. PubMed ID: 20981411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A.
    Gessa GL; Casu MA; Carta G; Mascia MS
    Eur J Pharmacol; 1998 Aug; 355(2-3):119-24. PubMed ID: 9760025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.
    Li Z; Prus AJ; Dai J; Meltzer HY
    J Pharmacol Exp Ther; 2009 Sep; 330(3):948-55. PubMed ID: 19491322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.